Spots Global Cancer Trial Database for vincristin
Every month we try and update this database with for vincristin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil | NCT05959720 | Acute Lymphoid ... Minimal Residua... Gene Abnormalit... Chemotherapeuti... | Prednisone Vincristin Daunorubicin Peg-asparaginas... Intrathecal Sus... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin | 16 Years - 50 Years | Instituto do Cancer do Estado de São Paulo | |
| Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil | NCT05959720 | Acute Lymphoid ... Minimal Residua... Gene Abnormalit... Chemotherapeuti... | Prednisone Vincristin Daunorubicin Peg-asparaginas... Intrathecal Sus... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin | 16 Years - 50 Years | Instituto do Cancer do Estado de São Paulo | |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 | NCT06284122 | Follicular Lymp... | Mosunetuzumab Lenalidomide Rituximab Obinutuzumab Cyclophosphamid... Doxorubicin Vincristin Prednisone Rituximab Obinutuzumab Bendamustin | 18 Years - | The Lymphoma Academic Research Organisation | |
| Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma | NCT06251180 | B-cell Non-Hodg... | Rocbrutinib Rituximab Cyclophosphamid... doxorubicin Vincristin Prednisone | 18 Years - 70 Years | Guangzhou Lupeng Pharmaceutical Company LTD. | |
| Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma | NCT00575406 | Diffuse Large B... | Rituximab Cyclophosphamid... Doxorubicin liposomal Doxor... Vincristin Prednisolone | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 | NCT06284122 | Follicular Lymp... | Mosunetuzumab Lenalidomide Rituximab Obinutuzumab Cyclophosphamid... Doxorubicin Vincristin Prednisone Rituximab Obinutuzumab Bendamustin | 18 Years - | The Lymphoma Academic Research Organisation | |
| Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma | NCT00575406 | Diffuse Large B... | Rituximab Cyclophosphamid... Doxorubicin liposomal Doxor... Vincristin Prednisolone | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma | NCT06251180 | B-cell Non-Hodg... | Rocbrutinib Rituximab Cyclophosphamid... doxorubicin Vincristin Prednisone | 18 Years - 70 Years | Guangzhou Lupeng Pharmaceutical Company LTD. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
